{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:07:49Z","timestamp":1793030869148,"version":"4.5.0"},"reference-count":63,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1000021"],"award-info":[{"award-number":["G1000021"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M014533\/1"],"award-info":[{"award-number":["MR\/M014533\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["HPRU in Evaluation of Interventions"],"award-info":[{"award-number":["HPRU in Evaluation of Interventions"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Indirect estimation methods are required for estimating the size of populations where only a proportion of individuals are observed directly, such as problem drug users (PDUs). Capture\u2013recapture and multiplier methods are widely used, but have been criticized as subject to bias. We propose a new approach to estimating prevalence of PDU from numbers of fatal drug\u2010related poisonings (fDRPs) using linked databases, addressing the key limitations of simplistic \u2018mortality multipliers\u2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our approach requires linkage of data on a large cohort of known PDUs to mortality registers and summary information concerning additional fDRPs observed outside this cohort. We model fDRP rates among the cohort and assume that rates in unobserved PDUs are equal to rates in the cohort during periods out of treatment. Prevalence is estimated in a Bayesian statistical framework, in which we simultaneously fit regression models to fDRP rates and prevalence, allowing both to vary by demographic factors and the former also by treatment status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We report a case study analysis, estimating the prevalence of opioid dependence in England in 2008\/09, by gender, age group and geographical region. Overall prevalence was estimated as 0.82% (95% credible interval\u00a0=\u00a00.74\u20130.94%) of 15\u201364\u2010year\u2010olds, which is similar to a published estimate based on capture\u2013recapture analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our modelling approach estimates prevalence from drug\u2010related mortality data, while addressing the main limitations of simplistic multipliers. This offers an alternative approach for the common situation where available data sources do not meet the strong assumptions required for valid capture\u2013recapture estimation. In a case study analysis, prevalence estimates based on our approach were surprisingly similar to existing capture\u2013recapture estimates but, we argue, are based on a much more objective and justifiable modelling approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.15111","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:09:46Z","timestamp":1589220586000},"page":"2393-2404","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Estimating the prevalence of problem drug use from drug\u2010related mortality data"],"prefix":"10.1111","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4265-2854","authenticated-orcid":false,"given":"Hayley E.","family":"Jones","sequence":"first","affiliation":[{"name":"Population Health Sciences, Bristol Medical School University of Bristol  Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross J.","family":"Harris","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Surveillance and Control, Public Health England  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice C.","family":"Downing","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School University of Bristol  Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Pierce","sequence":"additional","affiliation":[{"name":"Division of Psychology and Mental Health, School of Health Sciences University of Manchester  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Millar","sequence":"additional","affiliation":[{"name":"Division of Psychology and Mental Health, School of Health Sciences University of Manchester  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Ades","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School University of Bristol  Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky J.","family":"Welton","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School University of Bristol  Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Presanis","sequence":"additional","affiliation":[{"name":"MRC Biostatistics Unit University of Cambridge  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"De Angelis","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Surveillance and Control, Public Health England  London UK"},{"name":"MRC Biostatistics Unit University of Cambridge  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9864-459X","authenticated-orcid":false,"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School University of Bristol  Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13063"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30375-3"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30373-X"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30085-8"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32277-3"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau1184"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14234"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jth125"},{"key":"e_1_2_10_10_1","first-page":"15","article-title":"Estimating the prevalence of problematic drug use: a review of methods and their application","volume":"54","author":"Hickman M.","year":"2002","journal-title":"Bull Narc"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280208094704"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14383"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.86.5.642"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064789"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-007-9248-5"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4785-7"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja15.00671"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.00795"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.01043"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280208094691"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6047"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/rssa.12011"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280208094701"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu056"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13222"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00326.x"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.9610146510.x"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyy132"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-016-0123-0"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.044446"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036192"},{"key":"e_1_2_10_32_1","first-page":"15","article-title":"Estimating drug prevalence: review of methods with special reference to developing countries","volume":"54","author":"Hickman M.","year":"2003","journal-title":"UN Bull Narcot"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1988.10478599"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdi073"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2233-z"},{"key":"e_1_2_10_36_1","series-title":"EMCDDA Scientific Monograph Series no. 1","first-page":"247","volume-title":"Estimating the Prevalence of Problem Drug Use in Europe","author":"Hartnoll R.","year":"1997"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.2196\/publichealth.7909"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/152.8.771"},{"key":"e_1_2_10_39_1","first-page":"909","article-title":"Problems with using capture\u2013recapture in epidemiology: an example of a measles epidemic","volume":"52","author":"Cormack R. M.","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"e_1_2_10_40_1","first-page":"3","volume-title":"Measuring Different Aspects of Problem Drug Use: Methodological Developments","author":"Hay G.","year":"2006"},{"key":"e_1_2_10_41_1","volume-title":"Estimates of the Prevalence of Opiate Use and\/or Crack Cocaine Use, 2008\/09: Sweep 5 report","author":"Hay G.","year":"2010"},{"key":"e_1_2_10_42_1","unstructured":"HayG. GannonM. CaseyJ. MillarT.Estimates of the prevalence of opiate use and\/or crack cocaine use 2009\/10: Sweep 6 report. Manchester: National Drug Evidence Centre University of Manchester and Glasgow: Centre for Drug Misuse Research University of Glasgow;2011."},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1214\/16-STS553"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304673"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009825"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2011.05.010"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.09.782"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5475"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03140.x"},{"key":"e_1_2_10_51_1","volume-title":"The Drug Data Warehouse: Linking Data on Drug Misusers and Drug\u2010Misusing Offenders","author":"Millar T.","year":"2012"},{"key":"e_1_2_10_52_1","volume-title":"Opioid use in England and Wales: Mortality, Crime and the Effectiveness of Treatment","author":"Pierce M.","year":"2016"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008929526011"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9868.00353"},{"key":"e_1_2_10_55_1","volume-title":"The Drug Data Warehouse: Linking Data on Drug Misusers and Drug\u2010Misusing Offenders","author":"Millar T.","year":"2012"},{"key":"e_1_2_10_56_1","first-page":"493","article-title":"All\u2010cause and cause\u2010specific mortality among people using extramedical opioids","volume":"77","author":"Larney S.","year":"2019","journal-title":"JAMA"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.12.108282"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(97)00016-0"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3172"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.03.005"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12185"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-985X.2005.00377.x"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834021ed"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12948"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.15111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.15111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.15111","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.15111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:04:56Z","timestamp":1780985096000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.15111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1111\/add.15111"],"URL":"https:\/\/doi.org\/10.1111\/add.15111","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"2019-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}